Cascade Investment Group, Inc. Bio Techne Corp Call Options Transaction History
Cascade Investment Group, Inc.
- $134 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TECH
# of Institutions
581Shares Held
154MCall Options Held
180KPut Options Held
189K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.31 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY17.7MShares$1.27 Billion0.03% of portfolio
-
State Street Corp Boston, MA6.37MShares$456 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.75MShares$412 Million0.05% of portfolio
-
Bamco Inc New York, NY5MShares$358 Million0.95% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.81B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...